CYP2C19 Genotype Is Associated With Adverse Cardiovascular Outcomes in Black Patients Treated With Clopidogrel Undergoing Percutaneous Coronary Intervention.
Tunehag KR, Thomas CD, Franchi F, Rossi JS, Keeley EC, Anderson RD, Beitelshees AL, Duarte JD, Gong Y, Kerensky RA, McDonough CW, Nguyen AB, Ortega-Paz L, Venkatesh S, Wang Y, Johnson JA, Winterstein AG, Stouffer GA, Angiolillo DJ, Cavallari LH, Lee CR.
Tunehag KR, et al. Among authors: lee cr.
J Am Heart Assoc. 2024 Jun 14:e033791. doi: 10.1161/JAHA.123.033791. Online ahead of print.
J Am Heart Assoc. 2024.
PMID: 38874073